 




<RINDOCK>[Notice 94086]</RINDOCK>



<DOCTITLE>Intent To Grant a Partially Exclusive Patent License</DOCTITLE>


<AGENCY>
AGENCY: 

National Aeronautics and Space Administration.


</AGENCY>
<ACTION>
ACTION: 

Notice of intent to grant a patent license.



</ACTION>
<SUMMARY>
SUMMARY: 

NASA hereby gives notice of intent to grant Supra Medical Corporation, of Chadds Ford, Pennsylvania 19317, a partially
exclusive license to practice the invention protected by U.S. Patent Application, Serial No. 08/195,500 entitled
``METHOD AND APPARATUS FOR NON-INVASIVE EVALUATION OF DIAPHRAGMATIC FUNCTION'', which was filed on February 14,
1994, by the United States of America as represented by the Administrator of the National Aeronautics and Space Administration.
The partially exclusive license will contain appropriate terms and conditions to be negotiated in accordance with
NASA Patent Licensing Regulations (14 CFR 1245). NASA will negotiate the final terms and conditions and grant the
license unless, within 60 days of the date of this notice, the Director of Patent Licensing receives written objections
to the grant, together with supporting documentation. The Director of Licensing will review all written responses
to the notice and then recommend to the Associate General Counsel (Intellectual Property) whether to grant the license.


</SUMMARY>
<DATE>
DATES: 

Comments to the notice must be received by December 27, 1994.


</DATE>
<ADDRESS>
ADDRESSES: 

National Aeronautics and Space Administration, Code GP, Washington, DC 20546.


</ADDRESS>
<FURTHER>
FOR FURTHER INFORMATION CONTACT: 

Mr. Harry Lupuloff, NASA, Director of Patent Licensing, (202) 3582041.



Dated: October 18, 1994.

</FURTHER>
<SIGNER>
Edward A. Frankle,

</SIGNER>
<SIGNJOB>
General Counsel.

</SIGNJOB>
<FRFILING>
[FR Doc. 9426678 Filed 102794; 8:45 am]

</FRFILING>
<BILLING>
BILLING CODE 751001M
</BILLING>


